RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | Respiratory Tract Infections |
|
Accession: | DOID:9008680
|
browse the term
|
Definition: | Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. |
Synonyms: | exact_synonym: | Respiratory Infection, Upper; Respiratory Infections; Respiratory Tract Infection; Upper Respiratory Infections; Upper Respiratory Tract Infections |
| primary_id: | MESH:D012141; RDO:0000329 |
|
|
|
G |
Bdnf |
brain derived neurotrophic factor |
|
ISO |
protein:decreased expression:platelet, serum |
RGD |
PMID:17317133 |
RGD:4891069 |
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IMP |
|
RGD |
PMID:19039768 |
RGD:4892119 |
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
|
|
G |
Fbln5 |
fibulin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12189163 |
|
NCBI chr12:101,712,820...101,785,541
Ensembl chr12:101,712,824...101,785,314
|
|
G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
ISO |
|
RGD |
PMID:19775370 |
RGD:5144114 |
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
Severe Acute Respiratory Syndrome |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il16 |
interleukin 16 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr 7:83,292,027...83,395,479
Ensembl chr 7:83,292,033...83,394,934
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
associated with Asthma |
RGD |
PMID:20573437 |
RGD:5128554 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6ra |
interleukin 6 receptor, alpha |
|
ISO |
DNA:polymorphisms:promoter, exon:-183G>A (human) |
RGD |
PMID:20951753 |
RGD:5128631 |
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IMP |
|
RGD |
PMID:10497103 |
RGD:5128721 |
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
IMP |
|
RGD |
PMID:17027894 |
RGD:5128795 |
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17229951 |
|
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
susceptibility |
ISO |
DNA:polymorphisms:5' utr, exon:multiple (human) protein:decreased secretion:serum (human) DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:19767106 PMID:19169708 PMID:15249448 |
RGD:4889439, RGD:4889453, RGD:8693755 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Mx1 |
MX dynamin-like GTPase 1 |
|
ISO |
protein:increased expression:blood (human) |
RGD |
PMID:25542463 |
RGD:126777677 |
NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
|
|
G |
Rpgr |
retinitis pigmentosa GTPase regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12920075 |
|
NCBI chr X:10,024,455...10,083,034
Ensembl chr X:9,939,860...10,083,159
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
Severe Acute Respiratory Syndrome; protein:increased expression:serum |
RGD |
PMID:14633438 |
RGD:4145665 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
associated with Cystic Fibrosis |
RGD |
PMID:17898016 |
RGD:4145612 |
NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
IMP |
|
RGD |
PMID:15951834 |
RGD:5688155 |
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IMP |
|
RGD |
PMID:10946288 |
RGD:8661731 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
ISO |
DNA:mutations: : |
RGD |
PMID:11243954 |
RGD:4140482 |
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
susceptibility |
ISO |
associated with cystic fibrosis; DNA:polymorphisms: :DQB1*06:02, DQB1*02:01(human) |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
|
|
G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
susceptibility |
ISO |
associated with cystic fibrosis; DNA:polymorphisms: : |
RGD |
PMID:23278646 |
RGD:36049760 |
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
|
RGD |
PMID:7743671 |
RGD:8547590 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
susceptibility |
ISO |
Chronic Necrotizing Pulmonary Aspergillosis; DNA:missense mutation:exon:p.R52C (human) DNA:SNP:intron:1011G>A(human) |
RGD |
PMID:11474427 PMID:16487239 |
RGD:4889577, RGD:8693711 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Tlr9 |
toll-like receptor 9 |
susceptibility |
ISO IMP |
DNA:SNP:promoter:g.-1237T>C rs5743836 (human) |
RGD |
PMID:18275280 PMID:18936185 |
RGD:5130863, RGD:5130858 |
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tnf |
tumor necrosis factor |
|
IEP |
|
RGD |
PMID:8699818 |
RGD:7794730 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
susceptibility |
ISO |
DNA:snps:5' utr, exon:g.-609G>T rs4149570, g.36A>G rs767455 (human) |
RGD |
PMID:20646338 |
RGD:5131174 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
|
G |
Abcb1a |
ATP-binding cassette, sub-family B member 1A |
severity |
ISO |
DNA:snp:exon:c.1236C>T (human) |
RGD |
PMID:24040855 |
RGD:8657076 |
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
|
|
G |
Ace |
angiotensin I converting enzyme |
no_association |
ISO |
DNA:deletion:intron:IVS16+1464-1751del (human) |
RGD |
PMID:15112973 |
RGD:8142345 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (rat) |
RGD |
PMID:15362690 |
RGD:11522724 |
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29028686 |
|
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
treatment |
ISO |
|
RGD |
PMID:23089405 |
RGD:7248414 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl26 |
C-C motif chemokine ligand 26 |
|
ISO |
protein:increased expression:oronasal secretion (human) |
RGD |
PMID:23883806 |
RGD:7364793 |
NCBI chr 5:135,589,302...135,592,423
Ensembl chr 5:135,589,302...135,592,423
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:lymphocyte |
RGD |
PMID:19086656 |
RGD:8547782 |
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Cldn3 |
claudin 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr 5:135,015,068...135,016,330
Ensembl chr 5:135,015,068...135,016,326
|
|
G |
Cldn7 |
claudin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr11:69,855,605...69,858,712
Ensembl chr11:69,855,605...69,858,711
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
treatment |
IDA |
|
RGD |
PMID:10436391 |
RGD:11344920 |
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
F2 |
coagulation factor II |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:21711961 |
RGD:5147783 |
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
|
|
G |
Fcgr4 |
Fc receptor, IgG, low affinity IV |
susceptibility |
ISO |
DNA:polymorphism:exon:p.F158V(rs396991)(human) |
RGD |
PMID:18199088 |
RGD:5508449 |
NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330
|
|
G |
Gria1 |
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr11:56,902,342...57,221,070
Ensembl chr11:56,902,213...57,221,070
|
|
G |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34624383 |
|
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
|
|
G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
ISO |
|
RGD |
PMID:20487636 |
RGD:5144132 |
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hrh1 |
histamine receptor H1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23333628 |
|
NCBI chr 6:114,374,897...114,459,432
Ensembl chr 6:114,374,897...114,460,257
|
|
G |
Ifng |
interferon gamma |
treatment |
ISO |
associated with Asthma CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:29871060 PMID:12787306 PMID:18510219 |
RGD:7829803, RGD:10755770 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:36127783 PMID:23883806 PMID:23253209 |
RGD:7364793, RGD:7364818 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il13 |
interleukin 13 |
susceptibility no_association |
ISO |
DNA:polymorphism:exon:c. 2044G>A (human) CTD Direct Evidence: marker/mechanism DNA:missense mutation:cds:p.R130Q (rs20541) (human) DNA:SNPs:promoter, cds:-1112C>T, p.R130Q (rs1800925, rs20541) (human) DNA:SNP:promoter:-1512A>C (rs1881457) (human) |
CTD OMIM RGD |
PMID:17091279 PMID:22852128 PMID:12928861 PMID:23996716 |
RGD:4152796, RGD:8549518, RGD:8549516, RGD:8549501 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21462799 |
RGD:8549521 |
NCBI chr X:146,166,474...146,214,982
Ensembl chr X:146,166,472...146,212,188
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
DNA:snp:promoter:c.-444A>G (human) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:22507625 PMID:21535180 |
RGD:9068429, RGD:5147409 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
severity no_association |
ISO |
DNA:SNP:promoter:-137G>C (rs187238) (human) DNA:SNP:promoter:-140C>G (rs360721) (human) |
RGD |
PMID:22840759 PMID:22840759 |
RGD:8655914, RGD:8655914 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7750009 |
RGD:7401199 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
|
RGD |
PMID:12592663 |
RGD:8662963 |
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:36127783 PMID:9893928 PMID:24620662 PMID:8908280 PMID:14653048 |
RGD:7829796, RGD:11522769, RGD:7829827, RGD:7829802 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il5 |
interleukin 5 |
treatment |
ISO |
|
RGD |
PMID:23934070 PMID:24620662 |
RGD:11354976, RGD:11522769 |
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
|
|
G |
Itgb2 |
integrin beta 2 |
treatment |
ISO |
|
RGD |
PMID:12046991 |
RGD:9698435 |
NCBI chr10:77,366,164...77,401,542
Ensembl chr10:77,366,086...77,401,542
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:36127783 |
|
NCBI chr 2:14,234,225...14,336,834
Ensembl chr 2:14,234,203...14,336,868
|
|
G |
Muc1 |
mucin 1, transmembrane |
severity |
ISO |
mRNA,protein:decreased expression:nasal mucosa |
RGD |
PMID:31425778 PMID:31425778 PMID:31425778 |
RGD:127345100, RGD:127345100, RGD:127345100 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium |
RGD |
PMID:22972875 |
RGD:7364746 |
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:23858718 |
RGD:8547523 |
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Ocln |
occludin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33441633 |
|
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
|
|
G |
Pon1 |
paraoxonase 1 |
severity |
ISO |
protein:decreased activity:plasma (human) |
RGD |
PMID:23406590 |
RGD:8547583 |
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
|
|
G |
Prkg1 |
protein kinase, cGMP-dependent, type I |
|
ISO |
protein:increased expression:nasal cavity epithelium |
RGD |
PMID:24012634 |
RGD:7775060 |
NCBI chr19:30,541,887...31,742,675
Ensembl chr19:30,541,889...31,742,433
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16979129 |
|
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Scgb1a1 |
secretoglobin, family 1A, member 1 |
|
IEP |
mRNA:decreased expression:nasal mucosa, lung |
RGD |
PMID:17882576 |
RGD:5144135 |
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
|
|
G |
Scgb3a2 |
secretoglobin, family 3A, member 2 |
susceptibility |
ISO |
DNA:SNP: :rs7726552 (human) |
RGD |
PMID:21410962 |
RGD:5144225 |
NCBI chr18:43,897,346...43,900,464
Ensembl chr18:43,897,354...43,900,464
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
|
IEP |
mRNA:increased expression:nasal mucosa (mouse) |
RGD |
PMID:21339035 |
RGD:8547809 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Tacr1 |
tachykinin receptor 1 |
|
ISO |
mRNA:increased expression:nasal mucosa |
RGD |
PMID:12768696 |
RGD:5147835 |
NCBI chr 6:82,378,990...82,537,085
Ensembl chr 6:82,379,315...82,537,085
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
treatment |
ISO |
|
RGD |
PMID:31368266 |
RGD:14995445 |
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tlr2 |
toll-like receptor 2 |
severity |
ISO IDA |
DNA:polymorphism:cds:p.R753Q(human) protein:increased expression:neutrophil: mRNA:decreased expression:nasal mucosa: |
RGD |
PMID:22402138 PMID:22555057 PMID:18381801 PMID:18219831 |
RGD:7800732, RGD:8552993, RGD:8552972, RGD:7800742 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr4 |
toll-like receptor 4 |
severity treatment susceptibility no_association |
ISO |
DNA:polymorphism:cds:p.D299G(human) protein:increased expression:nasal lavage,leukocyte, bone marrow: protein:decreased expression:nasal mucosa: DNA:SNP: :rs1927911(human) DNA:polymorphism: :4216G>C(human) |
RGD |
PMID:22402138 PMID:22555057 PMID:22577387 PMID:17069098 PMID:23639307 PMID:19763595 More...
|
RGD:7800732, RGD:8552993, RGD:7800740, RGD:7800738, RGD:7800736, RGD:4145354 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
protein:decreased expression:nasal mucosa: |
RGD |
PMID:22577387 |
RGD:7800740 |
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
treatment |
ISO |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Cyp2c66 |
cytochrome P450, family 2, subfamily c, polypeptide 66 |
treatment |
ISO |
associated with Eosinophilic Esophagitis; DNA:polymorphisms:: |
RGD |
PMID:26416193 |
RGD:11352743 |
NCBI chr19:39,102,342...39,175,200
Ensembl chr19:39,102,342...39,175,516
|
|
G |
Il3 |
interleukin 3 |
susceptibility |
ISO |
DNA:SNP: :rs40401(human) |
RGD |
PMID:23953855 |
RGD:13506915 |
NCBI chr11:54,155,911...54,158,105
Ensembl chr11:54,156,129...54,158,103
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
DNA:SNP:promoter:-374T>A (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
IEP |
associated with Neutropenia;mRNA:increased expression:lung |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
IMP |
associated with Neutropenia |
RGD |
PMID:19783686 |
RGD:5130908 |
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
|
|
G |
Cd209d |
CD209d antigen |
|
ISO |
|
RGD |
PMID:21381282 |
RGD:5131183 |
NCBI chr 8:3,921,824...3,928,548
Ensembl chr 8:3,921,824...3,928,555
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
severity |
IMP |
|
RGD |
PMID:22135344 |
RGD:35673332 |
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
Clec1a |
C-type lectin domain family 1, member a |
susceptibility |
ISO |
ClinVar Annotator: match by term: Aspergillosis, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:25741868 PMID:29489751 |
|
NCBI chr 6:129,403,647...129,428,963
Ensembl chr 6:129,401,735...129,428,963
|
|
G |
Clec7a |
C-type lectin domain family 7, member a |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: CLEC7A-related condition |
CTD OMIM ClinVar |
PMID:19864674 PMID:20807886 PMID:24033266 PMID:25741868 PMID:28492532 |
|
NCBI chr 6:129,438,554...129,449,748
Ensembl chr 6:129,438,554...129,449,742
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
treatment |
ISO |
|
RGD |
PMID:20879853 |
RGD:9495929 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:16893395 |
RGD:4981337 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Mbl1 |
mannose-binding lectin (protein A) 1 |
susceptibility |
IMP |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr14:40,873,413...40,885,861
Ensembl chr14:40,873,415...40,881,558
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
susceptibility |
IMP |
|
RGD |
PMID:20064561 |
RGD:8694071 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
S100b |
S100 protein, beta polypeptide, neural |
|
ISO |
DNA:SNP: :427C>T (human) |
RGD |
PMID:22114731 |
RGD:8695981 |
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
|
|
G |
Tlr1 |
toll-like receptor 1 |
susceptibility |
ISO |
DNA:SNPs: :p.R80T, p.N248S (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 5:65,082,023...65,090,945
Ensembl chr 5:65,082,022...65,090,906
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:19781388 |
RGD:4145322 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr6 |
toll-like receptor 6 |
susceptibility |
ISO |
DNA:SNP: :p.S249P (human) |
RGD |
PMID:16461792 |
RGD:4889535 |
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
associated with Cerebrovascular Accident |
RGD |
PMID:14990394 |
RGD:4140926 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:19515386 |
RGD:4891456 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
protein:increased secretion:plasma (rat) |
RGD |
PMID:19262391 |
RGD:4145069 |
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15607125 |
|
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:Bronchoalveolar Lavage Fluid |
RGD |
PMID:18042282 |
RGD:4142854 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
severity |
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:24211414 |
RGD:40925940 |
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Marco |
macrophage receptor with collagenous structure |
disease_progression |
IMP |
association with Cryptococcal neoformans infection. |
RGD |
PMID:28298522 |
RGD:41412191 |
NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753
|
|
|
G |
Abcc1 |
ATP-binding cassette, sub-family C member 1 |
|
IMP |
|
RGD |
PMID:11238654 |
RGD:5128828 |
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
IEP |
associated with Pseudomonas Infections;mRNA, protein:altered expression, altered activity:lung (mouse) |
RGD |
PMID:31645418 |
RGD:40818279 |
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
severity |
IAGP |
|
RGD |
PMID:21629785 |
RGD:6767559 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
C3 |
complement component 3 |
|
IMP |
|
RGD |
PMID:16014897 |
RGD:5129508 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
C3ar1 |
complement component 3a receptor 1 |
|
IMP |
|
RGD |
PMID:16461429 |
RGD:5129690 |
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
|
|
G |
Cat |
catalase |
|
ISO |
|
RGD |
PMID:19842849 |
RGD:5130748 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IMP |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
IEP |
|
RGD |
PMID:20483921 |
RGD:5130905 |
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IMP |
|
RGD |
PMID:20042590 |
RGD:4891443 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
IMP |
|
RGD |
PMID:20176793 |
RGD:5130918 |
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
|
|
G |
Cd14 |
CD14 antigen |
|
IMP |
|
RGD |
PMID:16210672 |
RGD:4144197 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd40 |
CD40 antigen |
|
IEP |
|
RGD |
PMID:20102413 |
RGD:5132268 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd80 |
CD80 antigen |
|
IEP |
|
RGD |
PMID:20949109 |
RGD:4892562 |
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
|
|
G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
IEP |
|
RGD |
PMID:18643924 |
RGD:5133701 |
NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
disease_progression treatment |
ISO |
associated with Peritonitis; |
RGD |
PMID:21373266 PMID:12352049 |
RGD:5133733, RGD:11039437 |
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
disease_progression |
IMP |
|
RGD |
PMID:17185469 |
RGD:5133739 |
NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP ISO |
|
RGD |
PMID:21723409 PMID:11052817 |
RGD:5135062, RGD:5135234 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
severity |
IMP IEP |
|
RGD |
PMID:16299319 PMID:15618188 |
RGD:5135458, RGD:5135459 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
IEP |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
severity |
IEP ISO |
|
RGD |
PMID:21723409 PMID:11052817 PMID:19239431 |
RGD:5135062, RGD:5135234, RGD:5135065 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
|
RGD |
PMID:11052817 |
RGD:5135234 |
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
|
IEP |
|
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
IEP |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IMP |
|
RGD |
PMID:15618188 |
RGD:5135459 |
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
|
|
G |
Cyp2j6 |
cytochrome P450, family 2, subfamily j, polypeptide 6 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 4:96,404,375...96,449,835
Ensembl chr 4:96,404,375...96,441,898
|
|
G |
Cyp2j9 |
cytochrome P450, family 2, subfamily j, polypeptide 9 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:14766666 |
RGD:1625385 |
NCBI chr 4:96,456,661...96,480,748
Ensembl chr 4:96,456,666...96,479,815
|
|
G |
Defb3 |
defensin beta 3 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
|
|
G |
Defb4 |
defensin beta 4 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:10213993 |
RGD:4892266 |
NCBI chr 8:19,248,720...19,251,563
Ensembl chr 8:19,248,722...19,251,561
|
|
G |
F2 |
coagulation factor II |
|
ISO |
|
RGD |
PMID:21897338 |
RGD:6893486 |
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
|
|
G |
Fcgr3 |
Fc receptor, IgG, low affinity III |
|
IMP |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 1:170,878,738...170,893,477
Ensembl chr 1:170,878,743...170,892,504
|
|
G |
Foxp3 |
forkhead box P3 |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Gp1ba |
glycoprotein 1b, alpha polypeptide |
exacerbates |
IMP |
associated with Escherichia Coli Infections |
RGD |
PMID:27845343 |
RGD:42722624 |
NCBI chr11:70,529,928...70,534,812
Ensembl chr11:70,529,948...70,532,862
|
|
G |
Grk2 |
G protein-coupled receptor kinase 2 |
|
ISO |
mRNA:decreased expression:polymorphonuclear leukocyte |
RGD |
PMID:24465168 |
RGD:126848796 |
NCBI chr19:4,336,029...4,356,356
Ensembl chr19:4,336,029...4,356,250
|
|
G |
Hc |
hemolytic complement |
|
IMP |
|
RGD |
PMID:17975174 |
RGD:5129707 |
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP |
protein:increased expression:lung (mouse) |
RGD |
PMID:19846873 |
RGD:4145490 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifnar1 |
interferon (alpha and beta) receptor 1 |
severity |
IMP |
|
RGD |
PMID:19487810 |
RGD:5490274 |
NCBI chr16:91,281,016...91,307,411
Ensembl chr16:91,282,126...91,304,329
|
|
G |
Ifng |
interferon gamma |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il10 |
interleukin 10 |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il15 |
interleukin 15 |
|
IMP |
|
RGD |
PMID:17911627 |
RGD:5000754 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Il17a |
interleukin 17A |
severity |
IMP IEP |
|
RGD |
PMID:18802100 PMID:25398094 |
RGD:4889153, RGD:38501102 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
|
IMP |
|
RGD |
PMID:17664259 |
RGD:4889913 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1b |
interleukin 1 beta |
severity treatment |
IMP IEP ISO |
associated with Agranulocytosis |
RGD |
PMID:18596024 PMID:25398094 PMID:7546648 |
RGD:4143205, RGD:38501102, RGD:10755357 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rl1 |
interleukin 1 receptor-like 1 |
treatment |
IMP ISO |
associated with Sepsis associated with Acinetobacter infectious disease |
RGD |
PMID:20959556 PMID:29508184 |
RGD:5144223, RGD:40818077 |
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
IMP |
|
RGD |
PMID:18322242 PMID:18596024 |
RGD:4143206, RGD:4143205 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il22 |
interleukin 22 |
|
IMP |
|
RGD |
PMID:21178015 |
RGD:5147404 |
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
|
|
G |
Il6 |
interleukin 6 |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
|
IMP |
|
RGD |
PMID:28120642 PMID:20439918 |
RGD:34888234, RGD:36049799 |
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
|
|
G |
Irf1 |
interferon regulatory factor 1 |
|
IMP |
|
RGD |
PMID:11854220 |
RGD:5128725 |
NCBI chr11:53,660,841...53,669,200
Ensembl chr11:53,660,841...53,669,200
|
|
G |
Irf3 |
interferon regulatory factor 3 |
|
IMP |
|
RGD |
PMID:20720199 |
RGD:4891951 |
NCBI chr 7:44,647,072...44,652,272
Ensembl chr 7:44,647,072...44,652,272
|
|
G |
Itgb3 |
integrin beta 3 |
|
ISO |
protein:increased expression:lung, neutrophil |
RGD |
PMID:15114484 |
RGD:4993468 |
NCBI chr11:104,498,826...104,561,302
Ensembl chr11:104,498,826...104,561,302
|
|
G |
Lep |
leptin |
|
IMP |
|
RGD |
PMID:11937559 |
RGD:5128871 |
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
severity |
IMP |
associated with Escherichia Coli Infections |
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
ISO |
Legionella Pneumonia; DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:18641104 |
RGD:4889477 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Mc1r |
melanocortin 1 receptor |
|
IMP |
|
RGD |
PMID:18304533 |
RGD:5687324 |
NCBI chr 8:124,133,839...124,137,483
Ensembl chr 8:124,133,846...124,137,483
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IMP ISO |
protein:increased expression:bronchoalveolar lavage fluid |
RGD |
PMID:17202364 PMID:19535150 |
RGD:5130727, RGD:5129533 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased activity:bronchoalveolar lavage Fluid: |
RGD |
PMID:11269653 |
RGD:5130992 |
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
IMP |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
IMP |
|
RGD |
PMID:19360122 |
RGD:5131449 |
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Pdpn |
podoplanin |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:7864138 |
RGD:2292375 |
NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134
|
|
G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:12524254 |
RGD:724645 |
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
|
|
G |
Pgf |
placental growth factor |
|
IEP |
protein:increased expression:plasma |
RGD |
PMID:16702604 |
RGD:6483601 |
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
|
|
G |
Pten |
phosphatase and tensin homolog |
ameliorates |
IMP |
myeloid knockout |
RGD |
PMID:21527775 |
RGD:127285594 |
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
ameliorates |
IMP |
|
RGD |
PMID:28387756 |
RGD:127229944 |
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
|
|
G |
Rorc |
RAR-related orphan receptor gamma |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 3:94,280,106...94,305,583
Ensembl chr 3:94,280,101...94,305,583
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
severity |
IMP |
|
RGD |
PMID:17032919 |
RGD:4144840 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Sftpa1 |
surfactant associated protein A1 |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:12169586 |
RGD:4143464 |
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
|
|
G |
Sftpb |
surfactant associated protein B |
|
ISO |
associated with Cystic Fibrosis;protein:increased expression:lung |
RGD |
PMID:15271694 PMID:12169586 |
RGD:4143403, RGD:4143464 |
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
|
|
G |
Sftpc |
surfactant associated protein C |
|
IMP ISO |
|
RGD |
PMID:18566429 PMID:12169586 |
RGD:4144114, RGD:4143464 |
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
|
|
G |
Sftpd |
surfactant associated protein D |
|
ISO |
associated with Cystic Fibrosis;protein:decreased expression:lung protein:increased expression:lung |
RGD |
PMID:15271694 PMID:12169586 |
RGD:4143403, RGD:4143464 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
IMP |
|
RGD |
PMID:18192501 |
RGD:6892945 |
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
IEP |
|
RGD |
PMID:25398094 |
RGD:38501102 |
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IMP ISO |
|
RGD |
PMID:18768871 PMID:19844782 |
RGD:4145337, RGD:4889533 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
IMP |
|
RGD |
PMID:16210672 PMID:20650991 |
RGD:4144197, RGD:4144172 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tlr5 |
toll-like receptor 5 |
|
IMP |
|
RGD |
PMID:19801452 |
RGD:5129503 |
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
|
|
G |
Tlr6 |
toll-like receptor 6 |
|
ISO |
|
RGD |
PMID:19844782 |
RGD:4889533 |
NCBI chr 5:65,109,373...65,128,387
Ensembl chr 5:65,109,374...65,117,440
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
IMP |
|
RGD |
PMID:20360853 |
RGD:5130719 |
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tnf |
tumor necrosis factor |
disease_progression treatment severity |
ISO IMP |
associated with Agranulocytosis |
RGD |
PMID:10650487 PMID:7546648 PMID:9310939 PMID:12958055 |
RGD:4143476, RGD:10755357, RGD:10450564, RGD:10449451 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
IEP |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
IEP |
protein:increased expression:serum (mouse) |
RGD |
PMID:19842848 |
RGD:5131429 |
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
severity ameliorates |
ISO |
|
RGD |
PMID:24465168 PMID:16960786 PMID:22996209 |
RGD:126848796, RGD:127229902, RGD:126925987 |
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
|
|
G |
Zc3h12a |
zinc finger CCCH type containing 12A |
|
IMP |
associated with Pseudomonas Infections |
RGD |
PMID:29695841 |
RGD:39938967 |
NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633
|
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
|
ISO |
|
RGD |
PMID:17687719 |
RGD:4145098 |
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
severity |
ISO IMP |
protein:increased expression:nasal mucus associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17297249 PMID:15681407 |
RGD:4145460, RGD:4145415 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Cd40 |
CD40 antigen |
|
ISO |
|
RGD |
PMID:19470255 |
RGD:5132271 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd86 |
CD86 antigen |
|
IEP |
protein:decreased expression:myeloid dendritic cell (mouse) |
RGD |
PMID:20046053 |
RGD:4892291 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
severity |
ISO |
|
RGD |
PMID:21284715 |
RGD:5131282 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cysltr1 |
cysteinyl leukotriene receptor 1 |
|
IMP |
associated with Pneumovirus Infections |
RGD |
PMID:16337014 |
RGD:4843953 |
NCBI chr X:105,617,952...105,647,329
Ensembl chr X:105,617,952...105,647,285
|
|
G |
Il17a |
interleukin 17A |
susceptibility |
ISO |
DNA:SNP:promoter:rs2275913 (human) |
RGD |
PMID:20437253 |
RGD:4889139 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:8608647 |
RGD:4143192 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Muc5b |
mucin 5, subtype B, tracheobronchial |
|
ISO |
DNA:polymorphisms:promoter:rs885454,rs17235353, rs7115457 (human) |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
|
|
|
G |
Ace |
angiotensin I converting enzyme |
|
ISO |
|
RGD |
PMID:17097496 |
RGD:4140933 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Adora2a |
adenosine A2a receptor |
|
IMP |
|
RGD |
PMID:19766783 |
RGD:4890362 |
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
|
RGD |
PMID:18785972 |
RGD:4145604 |
NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
|
RGD |
PMID:14611812 |
RGD:2307195 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20628341 |
RGD:4891471 |
NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:lung (rat) |
RGD |
PMID:19840961 PMID:14611812 |
RGD:4889978, RGD:2307195 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
protein:increased expression:bronchoalveolar Lavage fluid |
RGD |
PMID:22215510 |
RGD:6483763 |
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IEP |
mRNA:increased expression:trachea: |
RGD |
PMID:11518728 |
RGD:4145124 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Cd86 |
CD86 antigen |
|
ISO |
|
RGD |
PMID:11266944 |
RGD:2307206 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
ISO |
associated with Respiratory Aspiration;protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IEP ISO IMP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:16709871 PMID:12097412 PMID:12097412 |
RGD:5135441, RGD:5135451, RGD:5135451 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl11 |
chemokine (C-X-C motif) ligand 11 |
|
IEP ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12097412 PMID:12097412 |
RGD:5135451, RGD:5135451 |
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
IEP ISO IMP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:16709871 PMID:12097412 PMID:12097412 |
RGD:5135441, RGD:5135451, RGD:5135451 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
IMP |
|
RGD |
PMID:16709871 PMID:12097412 |
RGD:5135441, RGD:5135451 |
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
human gene in a rat model |
RGD |
PMID:9595474 |
RGD:8662402 |
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:19840961 |
RGD:4889978 |
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Gzmb |
granzyme B |
|
ISO |
|
RGD |
PMID:19737140 |
RGD:5135518 |
NCBI chr14:56,496,293...56,499,791
Ensembl chr14:56,496,295...56,499,717
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IMP |
|
RGD |
PMID:12973103 |
RGD:4145412 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16137903 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il13 |
interleukin 13 |
|
IMP ISO |
|
RGD |
PMID:17182591 PMID:17182591 |
RGD:4146242, RGD:4146242 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il13ra1 |
interleukin 13 receptor, alpha 1 |
|
IEP |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:35,375,761...35,434,915
Ensembl chr X:35,375,763...35,434,912
|
|
G |
Il13ra2 |
interleukin 13 receptor, alpha 2 |
|
IMP |
|
RGD |
PMID:17182591 |
RGD:4146242 |
NCBI chr X:146,166,474...146,214,982
Ensembl chr X:146,166,472...146,212,188
|
|
G |
Il17a |
interleukin 17A |
|
IEP |
mRNA:increased expression:trachea |
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11889437 |
RGD:4143176 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18557728 |
RGD:2317286 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
|
RGD |
PMID:20393404 |
RGD:4143277 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
resistance |
ISO |
DNA:transversion:5' utr:-290C>G rs7096206 (human) |
RGD |
PMID:19104434 |
RGD:4889456 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression, increased activity:bronchoalveolar lavage fluid |
RGD |
PMID:20417130 |
RGD:5130759 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Muc1 |
mucin 1, transmembrane |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16969297 |
RGD:5131273 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
ISO |
|
RGD |
PMID:18158963 |
RGD:5131450 |
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
associated with lung transplantation; protein:increased expression:lung |
RGD |
PMID:11112135 |
RGD:4892082 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:15136885 |
RGD:4892068 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Scgb1a1 |
secretoglobin, family 1A, member 1 |
|
ISO |
associated with lung transplantation; protein:decreased expression:serum,bronchoalveolar lavage |
RGD |
PMID:11981419 |
RGD:5147386 |
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
|
|
G |
Sftpd |
surfactant associated protein D |
|
ISO |
|
RGD |
PMID:18347569 |
RGD:4143500 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
ISO |
DNA:SNPs:promoter, 3' utr:g.-1485C>T (rs187084), rs352162 (human) |
RGD |
PMID:20227302 |
RGD:5130722 |
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Egr1 |
early growth response 1 |
|
IMP |
|
RGD |
PMID:17384085 |
RGD:5132266 |
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Hdac2 |
histone deacetylase 2 |
treatment |
ISO |
|
RGD |
PMID:22708526 |
RGD:9590258 |
NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885
|
|
G |
Ifng |
interferon gamma |
resistance |
IDA |
|
RGD |
PMID:20953328 |
RGD:4145525 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:20350425 |
RGD:4892019 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
disease_progression |
IMP |
associated with Plague |
RGD |
PMID:21356370 |
RGD:5134954 |
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
ISO |
associated with Down Syndrome; protein:decreased secretion:serum (human) |
RGD |
PMID:19804807 |
RGD:4889483 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
|
G |
Cd274 |
CD274 antigen |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495
|
|
G |
Pdcd1 |
programmed cell death 1 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:26378990 |
RGD:41412180 |
NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278
|
|
G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta |
severity |
IMP |
|
RGD |
PMID:29893841 |
RGD:40890270 |
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
|
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
ISO |
|
RGD |
PMID:11991282 |
RGD:4145442 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
susceptibility |
ISO |
DNA:deletion: :F508del(human) associated with pulmonary disease chronic obstructive; DNA:missense mutation:exon:p.R75Q(human) |
RGD |
PMID:10767489 PMID:15463907 |
RGD:4140484, RGD:4140475 |
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
DNA:SNPs: :multiple (human) |
RGD |
PMID:19386687 |
RGD:4891509 |
NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
DNA:polymorphism (human) |
RGD |
PMID:14593914 |
RGD:4889126 |
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
|
|
G |
Edn1 |
endothelin 1 |
|
IEP |
Chronic Allergic Airway Inflammation; protein:increased secretion:bronchoalveolar lavage (mouse) |
RGD |
PMID:18631350 |
RGD:4145074 |
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
G |
Gc |
vitamin D binding protein |
susceptibility |
ISO |
|
RGD |
PMID:12096683 |
RGD:5129516 |
NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757
|
|
G |
Gstm1 |
glutathione S-transferase, mu 1 |
severity |
ISO |
DNA:deletion: : DNA:deletion, haplotype: : (human) |
RGD |
PMID:9187680 PMID:15125256 |
RGD:4142513, RGD:12798508 |
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
|
|
G |
Gstt1 |
glutathione S-transferase, theta 1 |
susceptibility |
ISO |
DNA:deletion: : |
RGD |
PMID:15928955 |
RGD:4142512 |
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:bronchial epithelium (rat) |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:19507274 |
RGD:2308951 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:increased expression:Respiratory Mucosa |
RGD |
PMID:14582911 |
RGD:4759835 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:11742275 |
RGD:4990461 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:11798689 |
RGD:5130990 |
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
|
RGD |
PMID:19938219 |
RGD:4891494 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Npy |
neuropeptide Y |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9731035 |
|
NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19263519 |
|
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
protein:increased expression:inferior turbinate, nasal gland, inflammatory cell (human) |
RGD |
PMID:8845175 |
RGD:8661738 |
NCBI chr13:42,454,952...42,461,466
Ensembl chr13:42,454,952...42,461,466
|
|
|
G |
Cd8a |
CD8 subunit alpha |
ameliorates |
ISO |
protein:decreased expression:blood, T cell (human) |
RGD |
PMID:24639246 |
RGD:124715444 |
NCBI chr 6:71,350,411...71,356,155
Ensembl chr 6:71,350,411...71,356,157
|
|
G |
Il17a |
interleukin 17A |
|
ISO |
protein:increased expression:uncinate process, nasal mucosa (human) |
RGD |
PMID:23613503 |
RGD:8696039 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
susceptibility |
ISO |
DNA:repeats:intron:IVS2+914_1000dup I/II alleles (human) |
RGD |
PMID:16549749 |
RGD:8549791 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
ISO |
protein:decreased activity:serum: |
RGD |
PMID:23144819 |
RGD:8693716 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Prg2 |
proteoglycan 2, bone marrow |
disease_progression |
ISO |
associated with Nasal Polyps; |
RGD |
PMID:24450586 |
RGD:13506943 |
NCBI chr 2:84,810,805...84,813,977
Ensembl chr 2:84,810,805...84,813,976
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:bronchus |
RGD |
PMID:11865407 |
RGD:4890421 |
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:15764644 |
RGD:5135489 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
treatment |
ISO |
|
RGD |
PMID:28343401 |
RGD:150521550 |
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
associated with Pulmonary Disease, Chronic Obstructive;protein:increased expression:respiratory epithelial cell |
RGD |
PMID:20395558 |
RGD:4145446 |
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
associated with Asthma |
RGD |
PMID:12751040 |
RGD:5135264 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
IMP |
|
RGD |
PMID:19864593 |
RGD:5131210 |
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
|
|
G |
Defb3 |
defensin beta 3 |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
|
|
G |
Defb4 |
defensin beta 4 |
|
ISO |
mRNA, protein:increased expression:nasal cavity epithelium, nasal mucus |
RGD |
PMID:15034083 |
RGD:4892264 |
NCBI chr 8:19,248,720...19,251,563
Ensembl chr 8:19,248,722...19,251,561
|
|
G |
Ifna2 |
interferon alpha 2 |
treatment |
ISO |
|
RGD |
PMID:6381610 |
RGD:40886344 |
NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
|
RGD |
PMID:20696083 |
RGD:4140458 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:10358201 |
RGD:4143183 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:7734976 |
RGD:7401200 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:18279051 PMID:10358201 |
RGD:4143207, RGD:4143183 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
protein:increased expression:nasal mucus |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
|
|
G |
Il4 |
interleukin 4 |
|
IEP |
associated with Asthma;mRNA, protein:increased expression:alveolar macrophage, respiratory system fluid/secretion |
RGD |
PMID:20644177 |
RGD:4140459 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Prdx5 |
peroxiredoxin 5 |
|
ISO |
associated with asthma;protein:increased expression:sputum (human) |
RGD |
PMID:18219526 |
RGD:41404684 |
NCBI chr19:6,884,065...6,887,474
Ensembl chr19:6,884,065...6,887,474
|
|
G |
Tslp |
thymic stromal lymphopoietin |
|
ISO |
protein:increased expression:nasal mucus (human) |
RGD |
PMID:28471975 |
RGD:38596342 |
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
|
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
ISO |
protein:increased expression:lung, macrophage (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
ISO |
protein:increased expression:lung, lymphocyte (human) |
RGD |
PMID:21144722 |
RGD:5131112 |
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
|
G |
Sftpc |
surfactant associated protein C |
|
IAGP |
OMIM:263000 |
MouseDO |
|
|
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
|
|
|
G |
H2-M2 |
histocompatibility 2, M region locus 2 |
susceptibility |
ISO |
DNA:polymorphism:cds:HLA-B*5401 (human) |
RGD |
PMID:9731015 |
RGD:1331522 |
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
susceptibility |
ISO |
DNA:SNP:exon:p.G54D(rs1800450)(human) |
RGD |
PMID:15249448 |
RGD:8693755 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Muc5ac |
mucin 5, subtypes A and C, tracheobronchial/gastric |
|
ISO |
protein:decreased expression:bronchiole epithelium |
RGD |
PMID:15364771 |
RGD:7364741 |
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
|
|
G |
Muc5b |
mucin 5, subtype B, tracheobronchial |
|
ISO |
DNA:insertion/deletion |
RGD |
PMID:15709052 |
RGD:7349353 |
NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
|
|
G |
Mucl3 |
mucin like 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22152429 |
|
NCBI chr17:35,946,647...35,954,587
Ensembl chr17:35,946,644...35,954,587
|
|
G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
susceptibility |
ISO |
DNA:polymorphisms:exon: |
RGD |
PMID:10323341 |
RGD:5147847 |
NCBI chr17:34,423,453...34,435,295
Ensembl chr17:34,422,501...34,435,295
|
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
protein:increased expression:ethmoid sinus |
RGD |
PMID:9800627 |
RGD:6483785 |
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
IEP |
|
RGD |
PMID:20045013 |
RGD:5129686 |
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Gata2 |
GATA binding protein 2 |
|
ISO |
associated with Pneumocystis Infections |
RGD |
PMID:16774119 |
RGD:9587813 |
NCBI chr 6:88,170,873...88,184,014
Ensembl chr 6:88,170,873...88,184,014
|
|
G |
Hc |
hemolytic complement |
|
IAGP |
|
RGD |
PMID:2612053 |
RGD:5130160 |
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
|
|
G |
Il13 |
interleukin 13 |
|
IEP ISO |
protein:increased expression:lung |
RGD |
PMID:19752036 PMID:16544260 |
RGD:4145474, RGD:4145506 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il33 |
interleukin 33 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:25746970 |
RGD:39938968 |
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
protein:decreased expression:lung |
RGD |
PMID:10639453 |
RGD:4891455 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Sftpa1 |
surfactant associated protein A1 |
susceptibility |
IMP |
|
RGD |
PMID:20413160 |
RGD:4143489 |
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
|
|
G |
Sftpd |
surfactant associated protein D |
susceptibility |
IMP ISO |
|
RGD |
PMID:20413160 PMID:20413160 |
RGD:4143489, RGD:4143489 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:lung |
RGD |
PMID:16544260 |
RGD:4145506 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
susceptibility |
ISO |
DNA:polymorphism:cds:allele AB (human) |
RGD |
PMID:6189297 PMID:4375858 |
RGD:5128836, RGD:39938844 |
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
|
|
G |
Apol6 |
apolipoprotein L 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:76,929,195...76,941,308
Ensembl chr15:76,928,929...76,941,306
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
|
|
G |
C3 |
complement component 3 |
|
IMP |
|
RGD |
PMID:21408070 |
RGD:5129492 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Casp1 |
caspase 1 |
|
IMP |
|
RGD |
PMID:19362023 |
RGD:5130181 |
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Cat |
catalase |
|
IDA ISO |
|
RGD |
PMID:20653246 PMID:16804020 PMID:19959187 |
RGD:5130201, RGD:5130864, RGD:5130744 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP |
associated with Asthma;protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:12707338 PMID:20656925 |
RGD:4145439, RGD:4145452 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:23326326 PMID:20967263 |
RGD:4891425 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl28 |
C-C motif chemokine ligand 28 |
resistance |
IMP |
|
RGD |
PMID:19847203 |
RGD:4892196 |
NCBI chr13:120,085,355...120,115,895
Ensembl chr13:120,085,355...120,115,895
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
susceptibility |
IMP IEP |
protein:increased expression:lung (mouse) |
RGD |
PMID:16208318 PMID:20656925 |
RGD:4892131, RGD:4145452 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
severity |
ISO IMP |
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human) |
RGD |
PMID:20875295 PMID:19039768 PMID:18617426 |
RGD:4892063, RGD:4892119, RGD:4892122 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Cd14 |
CD14 antigen |
|
IMP |
|
RGD |
PMID:17825924 |
RGD:4144809 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd209a |
CD209a antigen |
susceptibility |
ISO |
|
RGD |
PMID:21191006 |
RGD:5131189 |
NCBI chr 8:3,793,395...3,798,984
Ensembl chr 8:3,793,397...3,798,984
|
|
G |
Cd28 |
CD28 antigen |
|
IMP |
|
RGD |
PMID:21389258 |
RGD:5131611 |
NCBI chr 1:60,785,547...60,812,521
Ensembl chr 1:60,755,959...60,812,518
|
|
G |
Cd40 |
CD40 antigen |
|
IEP |
|
RGD |
PMID:19922665 |
RGD:5132270 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd80 |
CD80 antigen |
|
IAGP IEP |
|
RGD |
PMID:10604996 PMID:19922665 |
RGD:5132623, RGD:5132270 |
NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697
|
|
G |
Cd86 |
CD86 antigen |
|
IEP |
protein:increased expression:mediastinal lymph node, B cell (mouse) |
RGD |
PMID:19933871 |
RGD:4892570 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21509252 |
RGD:5131277 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
ISO IMP |
|
RGD |
PMID:20427198 PMID:21474645 |
RGD:5131472, RGD:5131470 |
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
protein:increased expression:lung, serum protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:17348295 PMID:20656925 |
RGD:4145366, RGD:4145452 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:21251691 PMID:20967263 |
RGD:5135026, RGD:4891425 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Ddx60 |
DExD/H box helicase 60 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 8:62,381,155...62,491,278
Ensembl chr 8:62,381,121...62,491,278
|
|
G |
Egr1 |
early growth response 1 |
|
IEP |
mRNA:increased expression:frontal cortex (mouse) |
RGD |
PMID:21289196 |
RGD:5131660 |
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
Eif2ak2 |
eukaryotic translation initiation factor 2-alpha kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
|
|
G |
Foxp2 |
forkhead box P2 |
|
IEP |
|
RGD |
PMID:18248790 |
RGD:11536002 |
NCBI chr 6:14,901,348...15,441,976
Ensembl chr 6:14,901,348...15,441,976
|
|
G |
Gbp2b |
guanylate binding protein 2b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
|
|
G |
H2-Eb1 |
histocompatibility 2, class II antigen E beta |
|
ISO |
|
RGD |
PMID:19386707 |
RGD:4144816 |
NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648
|
|
G |
H2-M3 |
histocompatibility 2, M region locus 3 |
|
ISO |
|
RGD |
PMID:21087648 |
RGD:5144131 |
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
|
|
G |
Herc6 |
hect domain and RLD 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:57,557,977...57,642,121
Ensembl chr 6:57,557,985...57,641,617
|
|
G |
Ifi27 |
interferon, alpha-inducible protein 27 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498
|
|
G |
Ifi35 |
interferon-induced protein 35 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524
|
|
G |
Ifi44 |
interferon-induced protein 44 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:151,436,559...151,455,580
Ensembl chr 3:151,436,559...151,455,597
|
|
G |
Ifi44l |
interferon-induced protein 44 like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:151,464,374...151,468,528
Ensembl chr 3:151,464,374...151,468,529
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
|
|
G |
Ifit2 |
interferon-induced protein with tetratricopeptide repeats 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr19:34,527,961...34,553,934
Ensembl chr19:34,528,094...34,553,819
|
|
G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr19:34,560,519...34,566,382
Ensembl chr19:34,560,931...34,566,131
|
|
G |
Ifitm3 |
interferon induced transmembrane protein 3 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Influenza, severe, susceptibility to |
CTD ClinVar OMIM |
PMID:20943977 PMID:22446628 PMID:23326326 |
|
NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683
|
|
G |
Il10 |
interleukin 10 |
susceptibility |
IMP |
|
RGD |
PMID:20200252 |
RGD:4140426 |
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il12b |
interleukin 12b |
|
IDA |
|
RGD |
PMID:16389596 |
RGD:4145426 |
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20003352 |
RGD:4888530 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il15 |
interleukin 15 |
|
IMP ISO IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:21098221 PMID:19234203 PMID:20212069 |
RGD:4994196, RGD:4996472, RGD:4996471 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Il15ra |
interleukin 15 receptor, alpha chain |
|
IDA |
|
RGD |
PMID:21098221 |
RGD:4994196 |
NCBI chr 2:11,709,992...11,739,129
Ensembl chr 2:11,710,101...11,739,128
|
|
G |
Il17a |
interleukin 17A |
|
IEP IMP |
mRNA, protein:increased expression:lung |
RGD |
PMID:19783685 PMID:19265125 |
RGD:4889102, RGD:4889150 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il17ra |
interleukin 17 receptor A |
|
IMP |
|
RGD |
PMID:19783685 |
RGD:4889102 |
NCBI chr 6:120,440,143...120,460,692
Ensembl chr 6:120,440,208...120,464,520
|
|
G |
Il18 |
interleukin 18 |
|
IMP |
|
RGD |
PMID:15606801 |
RGD:4889964 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:11535264 |
RGD:4142860 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
|
IDA |
|
RGD |
PMID:20438620 |
RGD:4142822 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:9439800 PMID:20840779 |
RGD:4143228, RGD:4143203 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21603856 |
RGD:5147905 |
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il22 |
interleukin 22 |
|
IEP IMP |
|
RGD |
PMID:21178015 PMID:20504940 |
RGD:5147404, RGD:5147405 |
NCBI chr10:118,040,456...118,045,952
Ensembl chr10:118,040,847...118,045,952
|
|
G |
Il4 |
interleukin 4 |
|
IEP |
|
RGD |
PMID:21092162 |
RGD:5128546 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il6 |
interleukin 6 |
|
IEP |
|
RGD |
PMID:20731583 |
RGD:4143268 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Irf7 |
interferon regulatory factor 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
|
|
G |
Isg15 |
ISG15 ubiquitin-like modifier |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253
|
|
G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:19,472,131...19,525,115
Ensembl chr16:19,472,128...19,525,125
|
|
G |
Ly6e |
lymphocyte antigen 6 family member E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:74,826,874...74,831,753
Ensembl chr15:74,826,900...74,831,752
|
|
G |
Lyst |
lysosomal trafficking regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr13:13,764,896...13,953,388
Ensembl chr13:13,764,982...13,953,388
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
IEP |
protein:increased activity:lung, heart, brain |
RGD |
PMID:20299740 |
RGD:5130855 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Mx1 |
MX dynamin-like GTPase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
|
|
G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
IEP |
protein:increased expression:hippocampus |
RGD |
PMID:9552178 |
RGD:5132870 |
NCBI chr 5:118,004,904...118,096,905
Ensembl chr 5:117,919,097...118,096,905
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
IMP IEP |
mRNA:increased expression:olfactory epithelium mRNA,protein:increased expression:brain |
RGD |
PMID:17030871 PMID:17674769 PMID:18080188 |
RGD:4891952, RGD:4891919, RGD:4891937 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Oas1g |
2'-5' oligoadenylate synthetase 1G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:121,014,205...121,025,676
Ensembl chr 5:121,014,205...121,025,676
|
|
G |
Oas2 |
2'-5' oligoadenylate synthetase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:120,868,398...120,887,949
Ensembl chr 5:120,868,398...120,887,918
|
|
G |
Oas3 |
2'-5' oligoadenylate synthetase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:120,891,163...120,915,755
Ensembl chr 5:120,891,163...120,915,726
|
|
G |
Oasl1 |
2'-5' oligoadenylate synthetase-like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 5:115,061,236...115,075,970
Ensembl chr 5:115,061,299...115,075,974
|
|
G |
Or5an1 |
olfactory receptor family 5 subfamily AN member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr19:12,257,218...12,261,352
Ensembl chr19:12,257,218...12,262,990
|
|
G |
Parp12 |
poly (ADP-ribose) polymerase family, member 12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 6:39,063,346...39,095,283
Ensembl chr 6:39,063,344...39,095,283
|
|
G |
Plscr1 |
phospholipid scramblase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:92,132,265...92,154,034
Ensembl chr 9:92,131,803...92,154,331
|
|
G |
Prf1 |
perforin 1 (pore forming protein) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26597256 |
|
NCBI chr10:61,133,530...61,140,463
Ensembl chr10:61,133,612...61,140,459
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
IMP |
|
RGD |
PMID:16272346 |
RGD:5143925 |
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Rigi |
RNA sensor RIG-I |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:40,203,775...40,239,843
Ensembl chr 4:40,203,773...40,239,828
|
|
G |
Rsad2 |
radical S-adenosyl methionine domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr12:26,492,742...26,506,451
Ensembl chr12:26,492,745...26,506,451
|
|
G |
Rtp4 |
receptor transporter protein 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr16:23,338,976...23,432,972
Ensembl chr16:23,339,041...23,432,972
|
|
G |
Sco2 |
SCO2 cytochrome c oxidase assembly protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr15:89,255,833...89,258,094
Ensembl chr15:89,255,840...89,258,049
|
|
G |
Serping1 |
serine (or cysteine) peptidase inhibitor, clade G, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
|
|
G |
Sftpd |
surfactant associated protein D |
|
IMP |
|
RGD |
PMID:16787926 |
RGD:4143518 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Siglec1 |
sialic acid binding Ig-like lectin 1, sialoadhesin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:130,911,140...130,928,697
Ensembl chr 2:130,911,140...130,928,685
|
|
G |
Slc22a8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23129053 |
|
NCBI chr19:8,568,576...8,589,199
Ensembl chr19:8,568,618...8,589,199
|
|
G |
Stat1 |
signal transducer and activator of transcription 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
|
|
G |
Tdrd7 |
tudor domain containing 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 4:45,965,335...46,034,766
Ensembl chr 4:45,965,334...46,034,761
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
protein:increased expression:monocyte |
RGD |
PMID:18657324 |
RGD:4145339 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr3 |
toll-like receptor 3 |
|
IEP IMP |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:16789835 PMID:18654661 |
RGD:5129219, RGD:5129136 |
NCBI chr 8:45,848,702...45,864,112
Ensembl chr 8:45,848,702...45,864,117
|
|
G |
Tmprss11d |
transmembrane protease, serine 11d |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20237084 PMID:23072892 |
|
NCBI chr 5:86,450,713...86,521,246
Ensembl chr 5:86,450,076...86,521,279
|
|
G |
Tmprss4 |
transmembrane protease, serine 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26889029 |
|
NCBI chr 9:45,084,024...45,115,417
Ensembl chr 9:45,084,024...45,115,390
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21062445 |
RGD:5128683 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfaip6 |
tumor necrosis factor alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:51,928,125...51,946,693
Ensembl chr 2:51,928,021...51,946,698
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
ISO IMP |
protein:increased expression:serum (human) |
RGD |
PMID:19497758 PMID:17182684 |
RGD:5131432, RGD:5131157 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
|
|
G |
Tor1b |
torsin family 1, member B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:30,842,951...30,854,085
Ensembl chr 2:30,842,971...30,849,027
|
|
G |
Trex1 |
three prime repair exonuclease 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 9:108,887,000...108,888,791
Ensembl chr 9:108,887,001...108,888,802
|
|
G |
Trim30a |
tripartite motif-containing 30A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 7:104,058,232...104,114,400
Ensembl chr 7:104,058,232...104,114,400
|
|
G |
Ube2l6 |
ubiquitin-conjugating enzyme E2L 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 2:84,629,172...84,640,347
Ensembl chr 2:84,629,172...84,640,679
|
|
G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:33639165 |
|
NCBI chr 4:59,189,452...59,222,833
Ensembl chr 4:59,189,257...59,222,833
|
|
G |
Xaf1 |
XIAP associated factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr11:72,192,229...72,204,560
Ensembl chr11:72,192,455...72,204,559
|
|
G |
Xist |
inactive X specific transcripts |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr X:102,503,979...102,526,839
Ensembl chr X:102,503,972...102,537,573
|
|
G |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23326326 |
|
NCBI chr 1:105,916,929...105,961,807
Ensembl chr 1:105,918,136...105,961,804
|
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
associated with Scleroderma, Diffuse protein:increased expression:serum |
RGD |
PMID:18432520 PMID:16085216 |
RGD:5135258, RGD:5135260 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
protein:increased expression:lung, alveolar macrophage (human) |
RGD |
PMID:19218648 |
RGD:4145518 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
protein:increased expression:bronchoalveolar lavage (rat) |
RGD |
PMID:10988147 |
RGD:11062092 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Keap1 |
kelch-like ECH-associated protein 1 |
|
ISO |
protein:increased expression:hyperplastic lung epithelium, alveolus (human) |
RGD |
PMID:20718723 |
RGD:6893300 |
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
|
|
G |
LOC110806267 |
Tert 5' regulatory region |
|
ISO |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:24033266 PMID:25741868 PMID:28492532 PMID:31268371 |
|
NCBI chr13:73,770,663...73,775,510
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
|
RGD |
PMID:21444868 |
RGD:7245946 |
NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140
|
|
G |
Scgb1a1 |
secretoglobin, family 1A, member 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:15467329 |
RGD:5144148 |
NCBI chr19:9,061,006...9,065,320
Ensembl chr19:9,061,000...9,065,322
|
|
G |
Tert |
telomerase reverse transcriptase |
|
ISO |
ClinVar Annotator: match by term: idiopathic fibrosing alveolitis |
ClinVar |
PMID:9536098 PMID:15814878 PMID:15885610 PMID:16247010 PMID:17460043 PMID:17576681 PMID:18042801 PMID:18460650 PMID:18635888 PMID:18931339 PMID:19561322 PMID:19674077 PMID:19760749 PMID:20301779 PMID:20502709 PMID:21436073 PMID:21520174 PMID:21602826 PMID:22853774 PMID:23538340 PMID:23716176 PMID:23901009 PMID:24033266 PMID:24763404 PMID:24833766 PMID:24983628 PMID:25365545 PMID:25741868 PMID:25785092 PMID:26024875 PMID:26136524 PMID:26580448 PMID:26859482 PMID:27192671 PMID:27418648 PMID:27540018 PMID:27848944 PMID:28104920 PMID:28492532 PMID:29036293 PMID:29483670 PMID:30426156 PMID:30523342 PMID:30791107 PMID:31268371 PMID:33709208 PMID:33850299 PMID:34019641 PMID:34482403 PMID:34565437 PMID:34890115 PMID:35776903 PMID:36622818 More...
|
|
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
|
|
|
G |
Atm |
ataxia telangiectasia mutated |
exacerbates |
IMP |
|
RGD |
PMID:31509427 |
RGD:126779564 |
NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
ameliorates |
IMP |
Associated with Acute Lung Injury |
RGD |
PMID:29516781 |
RGD:124713566 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
Duox1 |
dual oxidase 1 |
|
ISO |
protein:decreased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr 2:122,143,525...122,178,454
Ensembl chr 2:122,146,153...122,178,453
|
|
G |
Duox2 |
dual oxidase 2 |
severity |
IMP |
|
RGD |
PMID:28936773 PMID:25751630 PMID:29556357 |
RGD:40924644, RGD:40925925, RGD:40925921 |
NCBI chr 2:122,109,727...122,129,221
Ensembl chr 2:122,109,728...122,128,930
|
|
G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
IEP |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599
|
|
G |
Il21 |
interleukin 21 |
|
IMP |
|
RGD |
PMID:25251568 |
RGD:127285548 |
NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785
|
|
G |
Il27 |
interleukin 27 |
|
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:22343630 |
RGD:126790513 |
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
|
|
G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr17:56,426,678...56,428,946
Ensembl chr17:56,426,678...56,429,001
|
|
G |
Map3k8 |
mitogen-activated protein kinase kinase kinase 8 |
exacerbates |
IMP |
|
RGD |
PMID:26241898 |
RGD:11055126 |
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
ameliorates |
IMP |
|
RGD |
PMID:22514650 |
RGD:150340681 |
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
|
|
G |
Marco |
macrophage receptor with collagenous structure |
ameliorates |
IMP |
|
RGD |
PMID:21562316 |
RGD:41412197 |
NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
disease_progression |
IMP |
|
RGD |
PMID:27438481 |
RGD:40903047 |
NCBI chr 2:131,075,445...131,089,945
Ensembl chr 2:131,075,983...131,089,945
|
|
G |
Mir146 |
microRNA 146 |
exacerbates ameliorates |
IMP |
|
RGD |
PMID:31638222 PMID:30611999 |
RGD:126925152, RGD:126925153 |
NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288
|
|
G |
Mx1 |
MX dynamin-like GTPase 1 |
ameliorates |
IMP ISO |
fused with PTD 9-arginine sequence human gene in a mouse model |
RGD |
PMID:30696001 PMID:31653718 PMID:1371172 PMID:30945621 |
RGD:126777671, RGD:126777680, RGD:126777676, RGD:126777673 |
NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
|
|
G |
Plac8 |
placenta-specific 8 |
|
IMP |
|
RGD |
PMID:32639988 |
RGD:40925929 |
NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111
|
|
G |
Ppia |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human gene in a mouse model |
RGD |
PMID:27354005 |
RGD:150429624 |
NCBI chr11:6,365,867...6,369,817
Ensembl chr11:6,365,443...6,369,817
|
|
G |
Rigi |
RNA sensor RIG-I |
|
IEP |
mRNA:increased expression:nasal cavity mucosa (mouse) |
RGD |
PMID:25751630 |
RGD:40925925 |
NCBI chr 4:40,203,775...40,239,843
Ensembl chr 4:40,203,773...40,239,828
|
|
G |
Ripk3 |
receptor-interacting serine-threonine kinase 3 |
exacerbates susceptibility |
IMP |
|
RGD |
PMID:27321907 PMID:32200799 PMID:28410401 |
RGD:127229911, RGD:127229922, RGD:127229918 |
NCBI chr14:56,022,452...56,026,314
Ensembl chr14:56,022,452...56,026,322
|
|
G |
Saa1 |
serum amyloid A 1 |
|
ISO |
protein:increased expression:blood plasma (human) |
RGD |
PMID:24888898 |
RGD:40903071 |
NCBI chr 7:46,389,921...46,392,404
Ensembl chr 7:46,389,921...46,392,404
|
|
G |
Stat2 |
signal transducer and activator of transcription 2 |
exacerbates |
IMP |
|
RGD |
PMID:30337919 |
RGD:41789626 |
NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718
|
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
IMP |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr17:34,816,545...34,819,911
Ensembl chr17:34,816,836...34,819,910
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
severity |
IMP |
|
RGD |
PMID:11160230 |
RGD:11528533 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:20926800 |
RGD:7483599 |
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
disease_progression |
IMP |
|
RGD |
PMID:17379855 |
RGD:7483617 |
NCBI chr17:8,454,875...8,477,353
Ensembl chr17:8,454,875...8,475,973
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
|
RGD |
PMID:17298426 |
RGD:5135501 |
NCBI chr X:100,775,141...100,777,753
Ensembl chr X:100,775,141...100,777,875
|
|
G |
Cybb |
cytochrome b-245, beta polypeptide |
|
IMP |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr X:9,301,493...9,354,005
Ensembl chr X:9,301,491...9,354,010
|
|
G |
Cyp2c38 |
cytochrome P450, family 2, subfamily c, polypeptide 38 |
treatment |
ISO |
DNA:polymorphisms:cds: |
RGD |
PMID:26861072 |
RGD:124713410 |
NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519
|
|
G |
Elane |
elastase, neutrophil expressed |
|
IMP |
|
RGD |
PMID:24054721 |
RGD:10450528 |
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
|
|
G |
Il17a |
interleukin 17A |
severity |
IMP |
|
RGD |
PMID:21807912 |
RGD:8698654 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
|
ISO |
DNA:SNP:exon:rs5030737(human) |
RGD |
PMID:17311505 |
RGD:8693758 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Ptx3 |
pentraxin related gene |
severity |
ISO |
DNA:SNPs, missense mutation:intron, cds:rs2305619, rs1840680, rs3816527 protein:increased expression:bronchoalveolar lavage fluid (human) |
RGD |
PMID:30275011 PMID:28487045 |
RGD:38501097, RGD:38508892 |
NCBI chr 3:66,127,308...66,133,227
Ensembl chr 3:66,127,331...66,133,226
|
|
G |
S100b |
S100 protein, beta polypeptide, neural |
|
IMP |
|
RGD |
PMID:21423669 |
RGD:5508765 |
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IMP |
|
RGD |
PMID:16113258 |
RGD:8553022 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.D299G(human) |
RGD |
PMID:18275280 |
RGD:5130863 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
treatment |
ISO |
|
RGD |
PMID:12917249 |
RGD:11528529 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism, haplotype:promoter:-889C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
DNA:polymorphism, haplotype: :-511C>T (human) |
RGD |
PMID:18484169 |
RGD:4142867 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Itih4 |
inter alpha-trypsin inhibitor, heavy chain 4 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion, serum |
RGD |
PMID:24360996 |
RGD:40903005 |
NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
treatment |
ISO |
|
RGD |
PMID:17335555 |
RGD:8693746 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Ptx3 |
pentraxin related gene |
susceptibility no_association |
ISO |
DNA:SNP:intron:rs1840680 (human) protein:increased expression:bronchoalveolar lavage fluid, plasma (human) protein:increased expression:plasma DNA:SNP, missense mutation:intron, cds:rs2305619, rs3816527 |
RGD |
PMID:29020397 PMID:29964232 PMID:29020397 PMID:29020397 |
RGD:38501098, RGD:38508894, RGD:38501098, RGD:38501098 |
NCBI chr 3:66,127,308...66,133,227
Ensembl chr 3:66,127,331...66,133,226
|
|
G |
Vegfa |
vascular endothelial growth factor A |
treatment |
ISO |
|
RGD |
PMID:23303813 |
RGD:8655596 |
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
|
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
|
IMP |
|
RGD |
PMID:11207292 |
RGD:38549344 |
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Il23a |
interleukin 23, alpha subunit p19 |
severity |
IMP |
|
RGD |
PMID:16157683 |
RGD:39457940 |
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
|
|
G |
Irak3 |
interleukin-1 receptor-associated kinase 3 |
severity |
IMP IEP |
mRNA:increased expression:lung (mouse) |
RGD |
PMID:22729155 PMID:20864681 |
RGD:35316077, RGD:36049798 |
NCBI chr10:119,977,553...120,038,035
Ensembl chr10:119,977,553...120,038,035
|
|
G |
Lcn2 |
lipocalin 2 |
exacerbates ameliorates |
IMP IGI IEP |
protein:increased expression:lung protein:increased expression:serum |
RGD |
PMID:29633303 PMID:19342674 PMID:19342674 PMID:19342674 PMID:25234944 PMID:25234944 More...
|
RGD:126725082, RGD:126725085, RGD:126725085, RGD:126725085, RGD:126725084, RGD:126725084 |
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
|
|
G |
Plac8 |
placenta-specific 8 |
severity |
IMP |
|
RGD |
PMID:17404296 |
RGD:40924563 |
NCBI chr 5:100,699,455...100,720,119
Ensembl chr 5:100,701,591...100,720,111
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
disease_progression |
IMP |
|
RGD |
PMID:24396044 |
RGD:126925976 |
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
|
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IMP |
|
RGD |
PMID:16113250 |
RGD:4891897 |
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
|
IEP |
mRNA, protein:increased expression:lung |
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
IMP |
|
RGD |
PMID:11254553 |
RGD:5135252 |
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
|
|
G |
Ifng |
interferon gamma |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11349020 |
|
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il18 |
interleukin 18 |
|
IDA |
|
RGD |
PMID:11083766 |
RGD:4889865 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
susceptibility |
ISO |
|
RGD |
PMID:19073229 |
RGD:12910934 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
|
IMP |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 6:54,900,927...54,949,655
Ensembl chr 6:54,900,934...54,949,597
|
|
G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
IMP |
|
RGD |
PMID:20685341 |
RGD:5131443 |
NCBI chr 8:89,373,943...89,415,103
Ensembl chr 8:89,373,943...89,415,102
|
|
G |
Tlr5 |
toll-like receptor 5 |
susceptibility |
ISO IMP |
DNA:nonsense mutation:cds:p.R392X (human) ClinVar Annotator: match by term: Legionnaire disease, susceptibility to CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD RGD |
PMID:14623910 PMID:16027372 PMID:23447684 PMID:14623910 PMID:17982089 |
RGD:5129477, RGD:5129510 |
NCBI chr 1:182,782,317...182,804,010
Ensembl chr 1:182,782,353...182,804,010
|
|
G |
Tlr9 |
toll-like receptor 9 |
|
IMP |
|
RGD |
PMID:18426877 |
RGD:5130707 |
NCBI chr 9:106,099,797...106,104,075
Ensembl chr 9:106,099,797...106,104,082
|
|
G |
Tnfrsf1a |
tumor necrosis factor receptor superfamily, member 1a |
|
IMP |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
|
|
G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
IMP |
|
RGD |
PMID:18838275 |
RGD:5131445 |
NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440
|
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9255891 |
RGD:5128857 |
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Atp1b2 |
ATPase, Na+/K+ transporting, beta 2 polypeptide |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
IEP |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased secretion:lung, secretion (mouse) |
RGD |
PMID:18717637 |
RGD:4891914 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccl8 |
C-C motif chemokine ligand 8 |
|
IEP |
|
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
protein:increased expression:lung, T-helper cell (mouse) |
RGD |
PMID:16988274 |
RGD:4892091 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Clec5a |
C-type lectin domain family 5, member a |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 6:40,551,832...40,562,739
Ensembl chr 6:40,551,828...40,562,755
|
|
G |
Col3a1 |
collagen, type III, alpha 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866
|
|
G |
Col6a1 |
collagen, type VI, alpha 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr10:76,544,626...76,561,869
Ensembl chr10:76,544,626...76,562,002
|
|
G |
Col6a2 |
collagen, type VI, alpha 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
|
ISO |
|
RGD |
PMID:21426633 |
RGD:5131292 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Dnase1l3 |
deoxyribonuclease 1-like 3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr14:14,475,014...14,504,586
Ensembl chr14:14,475,200...14,505,240
|
|
G |
Fcer2a |
Fc receptor, IgE, low affinity II, alpha polypeptide |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 8:3,730,280...3,744,174
Ensembl chr 8:3,731,737...3,744,175
|
|
G |
Flt1 |
FMS-like tyrosine kinase 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:147,498,414...147,663,419
Ensembl chr 5:147,498,414...147,662,821
|
|
G |
Galc |
galactosylceramidase |
|
ISO IEP |
associated with Guillain-Barre syndrome; protein:increased expression:serum (human) associated with Guillain-Barre syndrome; protein:increased expression:Cerebrospinal fluid, serum (human) protein:increased expression:serum (mouse) |
RGD |
PMID:27490360 PMID:29301655 PMID:30396892 PMID:30396892 PMID:12225900 |
RGD:38599168, RGD:38599172, RGD:38599171, RGD:38599171, RGD:38599169 |
NCBI chr12:98,168,543...98,226,565
Ensembl chr12:98,168,553...98,225,718
|
|
G |
Hdc |
histidine decarboxylase |
|
IEP |
|
RGD |
PMID:17158962 |
RGD:5143920 |
NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219
|
|
G |
Htra3 |
HtrA serine peptidase 3 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 5:35,809,370...35,837,157
Ensembl chr 5:35,809,367...35,837,126
|
|
G |
Ifng |
interferon gamma |
|
IEP |
mRNA:increased expression:lung: |
RGD |
PMID:7935058 |
RGD:10755754 |
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il22ra2 |
interleukin 22 receptor, alpha 2 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr10:19,497,776...19,510,429
Ensembl chr10:19,497,746...19,510,429
|
|
G |
Inhba |
inhibin beta-A |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr13:16,178,841...16,206,194
Ensembl chr13:16,186,436...16,206,206
|
|
G |
Ms4a1 |
membrane-spanning 4-domains, subfamily A, member 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr19:11,227,043...11,243,513
Ensembl chr19:11,227,039...11,243,605
|
|
G |
Pld4 |
phospholipase D family member 4 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:112,727,089...112,735,420
Ensembl chr12:112,727,089...112,735,424
|
|
G |
Spib |
Spi-B transcription factor (Spi-1/PU.1 related) |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr 7:44,175,419...44,181,511
Ensembl chr 7:44,175,417...44,181,495
|
|
G |
Tcf7 |
transcription factor 7, T cell specific |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr11:52,137,347...52,174,211
Ensembl chr11:52,143,198...52,174,158
|
|
G |
Tcl1 |
T cell lymphoma breakpoint 1 |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr12:105,183,012...105,188,996
Ensembl chr12:105,183,009...105,189,052
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:20416219 |
RGD:4145765 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Tnfrsf13c |
tumor necrosis factor receptor superfamily, member 13c |
severity |
ISO |
|
RGD |
PMID:28302172 |
RGD:32716376 |
NCBI chr15:82,105,943...82,108,581
Ensembl chr15:82,105,944...82,108,570
|
|
|
G |
Ptch1 |
patched 1 |
|
ISO |
mRNA:decreased expression:epithelium of nasopharynx |
RGD |
PMID:23001130 |
RGD:150523839 |
NCBI chr13:63,656,142...63,721,274
Ensembl chr13:63,656,142...63,721,412
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19725899 |
RGD:5686851 |
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19389874 |
|
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
protein:increased expression:nasal turbinate |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 5:149,201,814...149,224,963
Ensembl chr 5:149,201,577...149,224,963
|
|
G |
Cat |
catalase |
|
ISO |
protein:decreased expression:plasma |
RGD |
PMID:20493834 |
RGD:5130771 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:nasal turbinate, mucosa (human) |
RGD |
PMID:9865755 |
RGD:8548839 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:Nasal Mucosa |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
mRNA:increased expression:nasal mucosa (human) |
RGD |
PMID:17982926 |
RGD:4145109 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Cd40 |
CD40 antigen |
|
IMP |
|
RGD |
PMID:20226305 |
RGD:5132269 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Cd86 |
CD86 antigen |
|
ISO |
protein:increased expression:nasal mucosa, dendritic cell (human) |
RGD |
PMID:17088138 |
RGD:4892343 |
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
|
|
G |
Chia1 |
chitinase, acidic 1 |
|
ISO |
mRNA, protein:increased expression:turbinate, mucosa (human) |
RGD |
PMID:20422678 |
RGD:5037226 |
NCBI chr 3:106,020,698...106,039,434
Ensembl chr 3:106,020,545...106,039,436
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
DNA:snp:5' utr:g.-4071A>G rs7729723 (human) |
RGD |
PMID:19833116 |
RGD:5131984 |
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
|
|
G |
F2rl1 |
F2R like trypsin receptor 1 |
|
ISO |
|
RGD |
PMID:17727088 |
RGD:4892590 |
NCBI chr13:95,648,226...95,661,748
Ensembl chr13:95,648,240...95,661,735
|
|
G |
Gstp1 |
glutathione S-transferase, pi 1 |
susceptibility |
ISO |
DNA:polymorphism:exon:p.I105V (rs1695) (human) |
RGD |
PMID:17181111 |
RGD:4142523 |
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
mRNA, protein:increased expression: nasal mucosa |
RGD |
PMID:16540907 |
RGD:4145406 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
IEP ISO |
protein:increased expression:lung, endothelium (mouse) protein:increased secretion:nasopharynx (human) |
RGD |
PMID:19968652 PMID:19047814 |
RGD:4145464, RGD:4145520 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Ifngr1 |
interferon gamma receptor 1 |
|
ISO |
DNA: SNP: Leu467Pro |
RGD |
PMID:12851715 |
RGD:6480431 |
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
mRNA, protein:increased expression:nasal mucosa |
RGD |
PMID:8520776 |
RGD:4782826 |
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
|
|
G |
Il17a |
interleukin 17A |
severity |
ISO |
protein:increased expression:serum |
RGD |
PMID:19226302 |
RGD:4889151 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNP:promoter:c. -607A>C (rs1946518) (human) |
RGD |
PMID:16406079 |
RGD:4889924 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
DNA:polymorphism:exon:c.4845G>T (human) |
RGD |
PMID:14533660 |
RGD:4142859 |
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
|
|
G |
Il1r1 |
interleukin 1 receptor, type I |
|
ISO |
|
RGD |
PMID:18637763 |
RGD:5037238 |
NCBI chr 1:40,261,651...40,355,361
Ensembl chr 1:40,264,240...40,356,417
|
|
G |
Il2 |
interleukin 2 |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:17608155 |
RGD:8662959 |
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
protein:increased expression:serum |
RGD |
PMID:21171297 PMID:9237816 PMID:15329007 |
RGD:5128559, RGD:7829817, RGD:7829804 |
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
protein: increased levels: sputum |
RGD |
PMID:22186238 |
RGD:5687140 |
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:nasal mucosa: |
RGD |
PMID:19786210 |
RGD:5130872 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
IEP |
protein:increased expression:nasal mucosa |
RGD |
PMID:14587983 |
RGD:4892078 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
ISO |
DNA:snp:promoter:g.-786T>C (human) |
RGD |
PMID:18086269 |
RGD:4892054 |
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
ISO |
protein:altered expression:nasal mucosa |
RGD |
PMID:20185258 |
RGD:4892593 |
NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474
|
|
G |
Pparg |
peroxisome proliferator activated receptor gamma |
|
ISO |
mRNA, protein:increased expression:nasal mucosa (human) |
RGD |
PMID:17116814 |
RGD:8552811 |
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
|
ISO |
protein:increased expression:respiratory system epithelium |
RGD |
PMID:19364335 |
RGD:5147461 |
NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
treatment |
ISO |
|
RGD |
PMID:15247523 |
RGD:11059532 |
NCBI chr10:81,164,102...81,171,008
Ensembl chr10:81,164,565...81,171,006
|
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
Gene product used in treatment of disease |
RGD |
PMID:20304453 |
RGD:4891955 |
NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453
|
|
G |
Tnc |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
treatment |
ISO |
|
RGD |
PMID:20819512 |
RGD:127284851 |
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
|
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased activity:pleural fluid: protein:increased activity:serum: protein:increased expression:serum: |
RGD |
PMID:21860532 PMID:1818842 PMID:1689629 PMID:18357489 |
RGD:152995280, RGD:152998934, RGD:152995292, RGD:152995288 |
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
|
RGD |
PMID:20337996 |
RGD:4891473 |
NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
|
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
ISO |
protein:increased expression:pleural fluid, natural killer cell (human) |
RGD |
PMID:19159432 |
RGD:4145106 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Foxp3 |
forkhead box P3 |
disease_progression |
ISO |
associated with human immunodeficiency virus infectious disease; |
RGD |
PMID:21303360 |
RGD:36947878 |
NCBI chr X:7,445,915...7,461,482
Ensembl chr X:7,439,883...7,461,484
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
DNA:polymorphism: :3953T>C (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
DNA:repeat (human) |
RGD |
PMID:10377182 |
RGD:4143226 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il27 |
interleukin 27 |
exacerbates |
ISO |
associated with Pleural Effusion;protein:increased expression:pleural fluid (human) protein:increased expression:alveolar system (human) |
RGD |
PMID:25753767 PMID:31819557 PMID:23962500 PMID:28844060 |
RGD:126790505, RGD:126790549, RGD:126790523, RGD:126790517 |
NCBI chr 7:126,188,181...126,194,197
Ensembl chr 7:126,188,182...126,194,113
|
|
G |
Il33 |
interleukin 33 |
|
ISO |
protein:increased expression:pleural fluid: |
RGD |
PMID:23301222 |
RGD:39939042 |
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:pleura: |
RGD |
PMID:18715875 |
RGD:5129700 |
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
|
RGD |
PMID:18295348 |
RGD:4144193 |
NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521
|
|
G |
Tnc |
tenascin C |
|
ISO |
protein:increased expression:pleura |
RGD |
PMID:10950882 |
RGD:4889594 |
NCBI chr 4:63,878,022...63,965,554
Ensembl chr 4:63,878,022...63,965,252
|
|
|
G |
Ada |
adenosine deaminase |
|
IDA |
|
RGD |
PMID:16860713 |
RGD:5128847 |
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
|
RGD |
PMID:9109363 |
RGD:4890429 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Anxa1 |
annexin A1 |
|
ISO |
|
RGD |
PMID:15784654 |
RGD:2306907 |
NCBI chr19:20,350,798...20,368,035
Ensembl chr19:20,350,792...20,368,308
|
|
G |
Bdkrb1 |
bradykinin receptor, beta 1 |
|
ISO |
|
RGD |
PMID:11853231 |
RGD:5129218 |
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
|
|
G |
Bdkrb2 |
bradykinin receptor, beta 2 |
|
IMP ISO |
|
RGD |
PMID:15316088 PMID:9208140 |
RGD:4891029, RGD:4891041 |
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
|
|
G |
C3 |
complement component 3 |
|
IEP |
protein:increased activity:pleural cavity |
RGD |
PMID:18256172 |
RGD:5129520 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Cat |
catalase |
|
IEP |
|
RGD |
PMID:19778612 |
RGD:5130749 |
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IEP ISO |
protein:increased expression:pleural fluid |
RGD |
PMID:11877329 PMID:11564646 |
RGD:4145443, RGD:4145479 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl25 |
C-C motif chemokine ligand 25 |
|
IEP |
protein:increased expression:pleural fluid |
RGD |
PMID:18056919 |
RGD:5130924 |
NCBI chr 8:4,375,207...4,410,020
Ensembl chr 8:4,375,210...4,410,020
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased secretion:lung (mouse) |
RGD |
PMID:18672096 |
RGD:4890016 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
IMP |
associated with Mycobacterium Infections |
RGD |
PMID:17158890 |
RGD:4145643 |
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
|
|
G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
ISO |
|
RGD |
PMID:8841835 |
RGD:11039424 |
NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IEP |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO IEP |
|
RGD |
PMID:21549112 PMID:14527170 |
RGD:5135064, RGD:5135449 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
IEP |
|
RGD |
PMID:14527170 |
RGD:5135449 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Ednra |
endothelin receptor type A |
|
IMP |
|
RGD |
PMID:15107459 |
RGD:4892325 |
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
|
|
G |
Elane |
elastase, neutrophil expressed |
|
ISO |
|
RGD |
PMID:20860667 |
RGD:10450565 |
NCBI chr10:79,722,146...79,724,050
Ensembl chr10:79,722,081...79,724,049
|
|
G |
Esr1 |
estrogen receptor 1 (alpha) |
|
ISO |
|
RGD |
PMID:17035596 |
RGD:4892303 |
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO IEP |
associated with Tuberculosis; protein:increased expression:pleural fluid, natural killer cell (human) CTD Direct Evidence: marker/mechanism protein:increased expression:bronchial epithelium (mouse) |
CTD RGD |
PMID:11181422 PMID:19714575 PMID:19056932 |
RGD:4145510, RGD:4145519 |
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
|
RGD |
PMID:10823416 |
RGD:4990464 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Il17a |
interleukin 17A |
treatment |
ISO |
|
RGD |
PMID:21898269 |
RGD:7175307 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:pleural cavity, exudate (rat) protein:increased expression:lung |
CTD RGD |
PMID:11181422 PMID:20141620 PMID:21898269 PMID:20175894 |
RGD:4142808, RGD:7175307, RGD:4142826 |
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
|
RGD |
PMID:8491511 |
RGD:4143233 |
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11181422 |
|
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Mpo |
myeloperoxidase |
|
IEP |
protein:increased activity:lung |
RGD |
PMID:11577999 |
RGD:5130991 |
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
|
|
G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
IMP |
|
RGD |
PMID:14673141 |
RGD:6893408 |
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
protein:increased expression:pleural cavity (rat) |
RGD |
PMID:21898269 PMID:20141620 |
RGD:7175307, RGD:4142808 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Pla2g6 |
phospholipase A2, group VI |
|
ISO |
|
RGD |
PMID:15003994 |
RGD:6482741 |
NCBI chr15:79,170,428...79,212,915
Ensembl chr15:79,170,428...79,212,590
|
|
G |
Ptafr |
platelet-activating factor receptor |
treatment |
ISO |
|
RGD |
PMID:8395390 |
RGD:10043147 |
NCBI chr 4:132,291,378...132,309,994
Ensembl chr 4:132,291,378...132,309,994
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
|
RGD |
PMID:20141620 PMID:15740981 |
RGD:4142808, RGD:5143929 |
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
|
|
G |
Selp |
selectin, platelet |
|
IEP ISO |
protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11181422 PMID:21147071 |
RGD:6219005 |
NCBI chr 1:163,942,833...163,977,595
Ensembl chr 1:163,942,833...163,977,595
|
|
G |
Serpine1 |
serine (or cysteine) peptidase inhibitor, clade E, member 1 |
susceptibility |
ISO |
associated with Familial Mediterranean Fever;DNA: DNA:polymorphism:promoter:rs1799768 (human): |
RGD |
PMID:23052617 |
RGD:13207414 |
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
|
|
G |
Tnf |
tumor necrosis factor |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11181422 PMID:11161459 PMID:20141620 |
RGD:4143474, RGD:4142808 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IMP |
|
RGD |
PMID:12773506 |
RGD:4890419 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
|
G |
Aicda |
activation-induced cytidine deaminase |
|
IMP |
|
RGD |
PMID:26456931 |
RGD:11098923 |
NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
IMP |
|
RGD |
PMID:20231413 |
RGD:4890435 |
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
|
|
G |
Btk |
Bruton agammaglobulinemia tyrosine kinase |
ameliorates |
IMP |
|
RGD |
PMID:30646846 |
RGD:124715470 |
NCBI chr X:133,443,083...133,484,366
Ensembl chr X:133,443,085...133,484,319
|
|
G |
C3 |
complement component 3 |
disease_progression |
IMP ISO |
protein:decreased expression:serum associated with Liver Cirrhosis, Experimental;protein:decreased expression:respiratory system fluid/secretion |
RGD |
PMID:15972516 PMID:20405 PMID:17956621 |
RGD:5129509, RGD:5130163, RGD:5129523 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
susceptibility |
IMP |
|
RGD |
PMID:16455992 |
RGD:4892130 |
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
|
|
G |
Cd14 |
CD14 antigen |
|
IMP |
|
RGD |
PMID:17185649 |
RGD:4144788 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Chi3l1 |
chitinase 3 like 1 |
|
ISO |
protein:increased secretion:serum (human) |
RGD |
PMID:10515841 |
RGD:4892626 |
NCBI chr 1:134,109,894...134,117,769
Ensembl chr 1:134,109,914...134,117,919
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
IMP |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr11:104,021,289...104,066,349
Ensembl chr11:104,023,681...104,066,349
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
IMP |
|
RGD |
PMID:21774994 |
RGD:5147472 |
NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
disease_progression |
ISO |
|
RGD |
PMID:21281676 |
RGD:5131293 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
IEP |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20958976 |
RGD:5134957 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:20381636 |
RGD:5135285 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Defb3 |
defensin beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 8:19,343,377...19,345,355
Ensembl chr 8:19,343,376...19,345,307
|
|
G |
Hc |
hemolytic complement |
severity |
IAGP |
|
RGD |
PMID:7814608 |
RGD:5130159 |
NCBI chr 2:34,873,341...34,958,518
Ensembl chr 2:34,873,343...34,951,450
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
IEP |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:17348295 |
RGD:4145366 |
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
|
|
G |
Hp |
haptoglobin |
|
ISO |
|
RGD |
PMID:19396720 |
RGD:5147385 |
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
|
|
G |
Il15 |
interleukin 15 |
|
IEP |
protein:increased expression:alveolar macrophage, bronchial epithelial cell |
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 8:83,058,253...83,129,883
Ensembl chr 8:83,058,261...83,129,851
|
|
G |
Il15ra |
interleukin 15 receptor, alpha chain |
|
IEP |
|
RGD |
PMID:17611121 |
RGD:5000755 |
NCBI chr 2:11,709,992...11,739,129
Ensembl chr 2:11,710,101...11,739,128
|
|
G |
Il17a |
interleukin 17A |
|
IDA |
|
RGD |
PMID:19995896 |
RGD:4888531 |
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
|
|
G |
Il18 |
interleukin 18 |
|
IMP |
|
RGD |
PMID:15770015 |
RGD:4889960 |
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
|
|
G |
Il6 |
interleukin 6 |
|
IDA |
|
RGD |
PMID:20643849 |
RGD:4143255 |
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
|
|
G |
Lep |
leptin |
|
IMP |
|
RGD |
PMID:17822444 |
RGD:5128869 |
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
|
|
G |
Lepr |
leptin receptor |
|
IMP |
|
RGD |
PMID:21148797 |
RGD:5128846 |
NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
|
|
G |
Masp2 |
MBL associated serine protease 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12904520 |
|
NCBI chr 4:148,679,079...148,699,939
Ensembl chr 4:148,687,011...148,699,956
|
|
G |
Mbl2 |
mannose-binding lectin (protein C) 2 |
no_association |
ISO |
DNA:polymorphisms:5' utr, exon:multiple (human) DNA:mutations:5' utr, exon:multiple (human) |
RGD |
PMID:12047967 PMID:18641104 |
RGD:4889478, RGD:4889477 |
NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
IMP |
|
RGD |
PMID:17056580 |
RGD:4891950 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Pten |
phosphatase and tensin homolog |
ameliorates |
IMP |
myeloid knockout |
RGD |
PMID:20505137 |
RGD:127285597 |
NCBI chr19:32,734,977...32,803,560
Ensembl chr19:32,734,897...32,803,560
|
|
G |
Sftpd |
surfactant associated protein D |
severity |
IMP |
|
RGD |
PMID:16255775 |
RGD:4143519 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Sirt1 |
sirtuin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24894820 |
|
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
|
|
G |
Sting1 |
stimulator of interferon response cGAMP interactor 1 |
|
IMP |
|
RGD |
PMID:29263110 |
RGD:39128230 |
NCBI chr18:35,866,731...35,873,607
Ensembl chr18:35,866,732...35,873,607
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IMP |
|
RGD |
PMID:19956717 |
RGD:4145321 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
G |
Tnf |
tumor necrosis factor |
|
IMP IEP |
associated with influenza;protein:increased expression:lung |
RGD |
PMID:9032201 PMID:17348295 |
RGD:4143479, RGD:4145366 |
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
|
|
G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
ameliorates |
IEP IDA |
|
RGD |
PMID:24752755 PMID:19596984 |
RGD:126928121, RGD:127229903 |
NCBI chr17:48,539,763...48,553,955
Ensembl chr17:48,539,796...48,553,952
|
|
|
G |
Azin1 |
antizyme inhibitor 1 |
|
ISO |
mRNA:increased expression:alveolar macrophage |
RGD |
PMID:19158080 |
RGD:14700806 |
NCBI chr15:38,487,674...38,523,506
Ensembl chr15:38,487,671...38,519,510
|
|
G |
C3 |
complement component 3 |
|
ISO |
|
RGD |
PMID:17169032 |
RGD:5129525 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:20618689 |
RGD:4891428 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Cd40 |
CD40 antigen |
treatment |
IDA |
|
RGD |
PMID:10968950 |
RGD:8547797 |
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
ISO |
protein:increased expression:respiratory system fluid/secretion |
RGD |
PMID:19487471 |
RGD:5131475 |
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
H2-Ab1 |
histocompatibility 2, class II antigen A, beta 1 |
|
ISO |
|
RGD |
PMID:20377877 |
RGD:4144112 |
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
|
|
G |
Il23a |
interleukin 23, alpha subunit p19 |
|
IMP |
|
RGD |
PMID:17403873 |
RGD:39458043 |
NCBI chr10:128,132,009...128,133,953
Ensembl chr10:128,132,008...128,134,621
|
|
G |
Il33 |
interleukin 33 |
treatment |
IDA |
|
RGD |
PMID:21220696 |
RGD:40400892 |
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
|
|
G |
Muc1 |
mucin 1, transmembrane |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9617869 |
RGD:5131424 |
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
|
|
G |
Nos2 |
nitric oxide synthase 2, inducible |
|
ISO |
protein:decreased dimerization:alveolar macrophage mRNA:increased expression:alveolar macrophage |
RGD |
PMID:20558778 PMID:20377877 |
RGD:4891486, RGD:4144112 |
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
|
|
G |
Sftpa1 |
surfactant associated protein A1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:40,853,745...40,858,330
Ensembl chr14:40,853,739...40,858,409
|
|
G |
Sftpb |
surfactant associated protein B |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
|
|
G |
Sftpc |
surfactant associated protein C |
|
IEP |
protein:decreased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:70,758,381...70,761,521
Ensembl chr14:70,758,389...70,761,521
|
|
G |
Sftpd |
surfactant associated protein D |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:11385364 |
RGD:4143431 |
NCBI chr14:40,894,169...40,907,155
Ensembl chr14:40,894,171...40,907,106
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
IMP |
|
RGD |
PMID:18400546 |
RGD:4145341 |
NCBI chr 3:83,743,579...83,749,045
Ensembl chr 3:83,743,579...83,749,074
|
|
|
G |
Abcf1 |
ATP-binding cassette, sub-family F member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:36,267,711...36,280,642
Ensembl chr17:36,267,711...36,280,653
|
|
G |
Abo |
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase |
severity |
ISO |
DNA:polymorphism:cds:allele A (human) |
RGD |
PMID:4375858 |
RGD:39938844 |
NCBI chr 2:26,732,508...26,754,973
Ensembl chr 2:26,732,515...26,754,991
|
|
G |
Ace |
angiotensin I converting enzyme |
disease_progression |
ISO |
associated with Hypertension |
RGD |
PMID:17727310 PMID:19455553 PMID:20051911 |
RGD:4140922, RGD:4140918, RGD:4140916 |
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
|
|
G |
Adora1 |
adenosine A1 receptor |
|
IMP |
|
RGD |
PMID:15630442 |
RGD:5129098 |
NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169
|
|
G |
Adora2a |
adenosine A2a receptor |
|
IMP IDA |
associated with Lung Injury associated with Anemia, Sickle Cell |
RGD |
PMID:18703794 PMID:17601796 PMID:20798237 |
RGD:4890364, RGD:4890376, RGD:4890358 |
NCBI chr10:75,152,711...75,170,626
Ensembl chr10:75,152,711...75,170,618
|
|
G |
Adrb2 |
adrenergic receptor, beta 2 |
|
ISO |
|
RGD |
PMID:19925785 |
RGD:4145041 |
NCBI chr18:62,310,784...62,313,052
Ensembl chr18:62,310,887...62,313,030
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28960804 |
|
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
|
|
G |
Ahr |
aryl-hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23337360 |
|
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:23286966 |
RGD:11035283 |
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
|
|
G |
Bdkrb2 |
bradykinin receptor, beta 2 |
|
IMP |
|
RGD |
PMID:15021973 |
RGD:4891030 |
NCBI chr12:105,529,431...105,561,503
Ensembl chr12:105,529,485...105,561,496
|
|
G |
C3 |
complement component 3 |
|
ISO |
|
RGD |
PMID:10886251 |
RGD:5129562 |
NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136
|
|
G |
C3ar1 |
complement component 3a receptor 1 |
|
IMP |
associated with Respiratory Syncytial Virus Infections |
RGD |
PMID:17079327 |
RGD:5129688 |
NCBI chr 6:122,824,099...122,833,116
Ensembl chr 6:122,824,097...122,833,120
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290
|
|
G |
Ccl11 |
C-C motif chemokine ligand 11 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:11290805 PMID:10595930 |
RGD:4145445, RGD:4145450 |
NCBI chr11:81,948,658...81,953,781
Ensembl chr11:81,948,649...81,953,781
|
|
G |
Ccl12 |
C-C motif chemokine ligand 12 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:81,992,671...81,994,225
Ensembl chr11:81,992,671...81,994,226
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
|
ISO |
mRNA:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:15993846 |
RGD:2306304 |
NCBI chr 8:95,535,996...95,538,666
Ensembl chr 8:95,537,081...95,538,664
|
|
G |
Ccl19 |
C-C motif chemokine ligand 19 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 4:42,754,525...42,756,558
Ensembl chr 4:42,754,525...42,756,577
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP ISO |
protein:increased expression:respiratory system fluid/secretion CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:19648283 |
RGD:4891461 |
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
|
|
G |
Ccl20 |
C-C motif chemokine ligand 20 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 1:83,094,487...83,096,888
Ensembl chr 1:83,094,487...83,096,888
|
|
G |
Ccl22 |
C-C motif chemokine ligand 22 |
|
ISO |
mRNA:increased expression:lung |
RGD |
PMID:15993846 |
RGD:2306304 |
NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327
|
|
G |
Ccl24 |
C-C motif chemokine ligand 24 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:135,598,789...135,601,977
Ensembl chr 5:135,598,791...135,601,903
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:15191918 |
RGD:5130985 |
NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351
|
|
G |
Ccl8 |
C-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
|
|
G |
Ccl9 |
C-C motif chemokine ligand 9 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462
|
|
G |
Ccr1 |
C-C motif chemokine receptor 1 |
|
IMP ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:20870892 |
RGD:5688175 |
NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
IMP ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:14615370 PMID:17284325 |
RGD:4145068, RGD:8661704 |
NCBI chr 9:123,901,954...123,913,594
Ensembl chr 9:123,901,987...123,913,594
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
IEP |
mRNA:increased expression:lung |
RGD |
PMID:19762220 |
RGD:4145622 |
NCBI chr 9:123,817,799...123,831,729
Ensembl chr 9:123,822,009...123,831,726
|
|
G |
Ccr5 |
C-C motif chemokine receptor 5 |
|
IEP |
Idiopathic Pneumonia Syndrome; mRNA:increased expression:lung (mouse) |
RGD |
PMID:15546955 |
RGD:4892103 |
NCBI chr 9:123,921,557...123,934,153
Ensembl chr 9:123,921,580...123,947,736
|
|
G |
Ccr6 |
C-C motif chemokine receptor 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr17:8,454,875...8,477,353
Ensembl chr17:8,454,875...8,475,973
|
|
G |
Ccr7 |
C-C motif chemokine receptor 7 |
|
ISO |
mRNA, protein:increased expression:lung |
RGD |
PMID:16394278 |
RGD:5130919 |
NCBI chr11:99,035,025...99,045,903
Ensembl chr11:99,035,022...99,045,903
|
|
G |
Ccr9 |
C-C motif chemokine receptor 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 9:123,596,276...123,612,522
Ensembl chr 9:123,507,504...123,613,395
|
|
G |
Cd14 |
CD14 antigen |
|
ISO |
protein:increased expression:multiple |
RGD |
PMID:20302606 |
RGD:4144794 |
NCBI chr18:36,858,117...36,859,868
Ensembl chr18:36,858,120...36,859,851
|
|
G |
Cd163 |
CD163 antigen |
|
ISO |
associated with liver disease;protein:increased expression:blood serum (human) |
RGD |
PMID:26339412 |
RGD:11251207 |
NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr X:56,257,448...56,269,402
Ensembl chr X:56,257,503...56,269,402
|
|
G |
Coq6 |
coenzyme Q6 monooxygenase |
|
ISO |
ClinVar Annotator: match by term: increased susceptibility to pneumonia |
ClinVar |
|
|
NCBI chr12:84,408,530...84,420,570
Ensembl chr12:84,408,431...84,420,570
|
|
G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
IMP |
|
RGD |
PMID:16855006 |
RGD:5130933 |
NCBI chr 6:55,067,033...55,110,001
Ensembl chr 6:55,067,034...55,110,001
|
|
G |
Crp |
C-reactive protein, pentraxin-related |
severity disease_progression |
ISO |
|
RGD |
PMID:21258955 PMID:21439658 |
RGD:5131283, RGD:5131291 |
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
|
|
G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:11732872 PMID:19633061 |
RGD:4142837 |
NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493
|
|
G |
Csf3r |
colony stimulating factor 3 receptor |
|
ISO |
mRNA:increased expression:bronchoalveolar lavage (human) |
RGD |
PMID:32407669 |
RGD:30296672 |
NCBI chr 4:125,917,241...125,938,233
Ensembl chr 4:125,918,343...125,938,233
|
|
G |
Csk |
c-src tyrosine kinase |
|
IMP |
|
RGD |
PMID:14975240 |
RGD:5134363 |
NCBI chr 9:57,533,929...57,560,758
Ensembl chr 9:57,533,929...57,560,914
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 8:95,498,808...95,509,055
Ensembl chr 8:95,498,637...95,509,055
|
|
G |
Cxcl1 |
C-X-C motif chemokine ligand 1 |
|
ISO |
mRNA, protein:increased expression:lung CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:20728373 |
RGD:5134959 |
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
IMP IEP |
associated with Lupus Erythematosus, Systemic;mRNA:increased expression:lung |
RGD |
PMID:15265940 PMID:14979941 |
RGD:5135445, RGD:5135491 |
NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748
|
|
G |
Cxcl15 |
C-X-C motif chemokine ligand 15 |
|
EXP |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
|
|
G |
Cxcl2 |
C-X-C motif chemokine ligand 2 |
|
ISO IEP |
mRNA, protein:increased expression:lung mRNA:increased expression:lung |
RGD |
PMID:20728373 PMID:18367723 |
RGD:5134959, RGD:5135235 |
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
|
|
G |
Cxcl5 |
C-X-C motif chemokine ligand 5 |
|
ISO |
protein:increased expression:sputum |
RGD |
PMID:18410262 |
RGD:5135259 |
NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO IMP |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:21625544 PMID:17052299 PMID:15265940 |
RGD:5135440, RGD:5135445 |
NCBI chr 5:92,469,190...92,475,938
Ensembl chr 5:92,469,206...92,475,938
|
|
G |
Cxcr2 |
C-X-C motif chemokine receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21625544 |
|
NCBI chr 1:74,193,153...74,200,405
Ensembl chr 1:74,193,150...74,200,405
|
 | |